CO157 Recurrence-Free Survival (RFS) As a Surrogate Endpoint for Overall Survival (OS) in Adults with Early-Stage Hepatocellular Carcinoma (HCC): A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS)
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.230
https://www.valueinhealthjournal.com/article/S1098-3015(23)00330-3/fulltext
Title :
CO157 Recurrence-Free Survival (RFS) As a Surrogate Endpoint for Overall Survival (OS) in Adults with Early-Stage Hepatocellular Carcinoma (HCC): A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00330-3&doi=10.1016/j.jval.2023.03.230
First page :
Section Title :
Open access? :
No
Section Order :
11621